Roser Solans Laque Institutions of which they are part Systemic Diseases Vall Hebron Institut de Recerca Email Roser Solans Laque Email Institutions of which they are part Systemic Diseases Vall Hebron Institut de Recerca
Research lines Spanish Registry of patients with Systemic vasculitides (REVAS). This is a multicentre study supported by the Systemic Autoimmune Diseases Group (GEAS) from the Spanish Internal Medicine Society (SEMI). The aim of the study is to describe the different clinical forms of presentation of these diseases, the response to the conventional treatment of the different subtypes of vasculitides, and the prognostic factors and survival in our country. This study includes 17 Hospitals from Spain with a cohort of 300 patients. We are the study coordinator Centre. IP: Roser Solans Laque Cardiac involvement in Churg-Strauss Granulomatosis (EGPE). Cardiac involvement is one of the most important causes of dead in EGPE. The aim of this study is to investigate the prevalence of silent cardiac involvement in patients with EGPE, and if some chemotaxins (eotaxins 1, 2 and 3) may play a key role in its development, in order to establish an early tretament. IP: Roser Solans Laque Risk factors for ischemic events in biopsy-proven Giant Cell Arteritis (GCA). The study aims to investigate the risk factors for ischemic complications in patients with GCA, and the role that some endothelial growth factors may play in its development. This study is coordinated by Dr. Gonzalez Gay from University Hospital of Valdecilla, Santander. IP: Roser Solans Laque International Classification Criteria project for neuro-Behçet disease. We are currently enrolled in this multicentre study coordinated by Dr. Seema Kalra from University Hospital of North Staffordshire (UK). The study aims to define new diagnostic criteria for neuro-Behçet disease. A set of neurologists, rheumatologists and specialists in Internal Medicine from different countries, experts in the diagnosis and management of this disease, will try to define a new set of diagnostic criteria based on clinical expertise, and in the most new laboratory and radiology modern tests. IP: Roser Solans Laque Pagination First page « Previous page ‹ Page 1 Current page 2 Page 3 Next page › Last page » Projects Autoimmunitat i malaltia trombòtica IP: Miguel Vilardell Tarres Collaborators: Carmen Pilar Simeón i Aznar, Ernesto Trallero Araguas, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Autoimmunitat i malaltia trombòtica, Josefina Cortes Hernandez, Fernando Martínez Valle, Jesus Castro Marrero, Albert Selva O'Callaghan Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 49920 Reference: 2009 SGR 661 Duration: 01/01/2010 - 30/04/2014 Autoimmunitat i malaltia trombòtica IP: Miguel Vilardell Tarres Collaborators: Carmen Pilar Simeón i Aznar, Roser Solans Laque, Antonio San Jose Laporte, Vicenç Fonollosa Pla, José Ordi Ros, Autoimmunitat i malaltia trombòtica, Albert Selva O'Callaghan, Maria Urquizu Padilla Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: Reference: 2005SGR 00279 Duration: 01/01/2006 - 31/12/2008 Pagination First page « Previous page ‹ Page 1 Current page 2
